ArticleCells2022

Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma.

Ashleigh Hull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.